Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis

Elisa Benedettini, Lynette M. Sholl, Michael Peyton, John Reilly, Christopher Ware, Lenora Davis, Natalie Vena, Dyane Bailey, Beow Y. Yeap, Michelangelo Fiorentino, Azra H. Ligon, Bo Sheng Pan, Victoria Richon, John D. Minna, Adi F. Gazdar, Giulio Draetta, Silvano Bosari, Lucian R. Chirieac, Bart Lutterbach, Massimo Loda

Research output: Contribution to journalArticlepeer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis'. Together they form a unique fingerprint.

Medicine & Life Sciences